Harrow Health (HROW) Misses Q3 EPS by 7c

Harrow Health (NASDAQ: HROW) reported Q3 EPS of ($0.12), $0.07 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $34.3 million versus the consensus estimate of $52.8 million.

For earnings history and earnings-related data on Harrow Health (HROW) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• SpaceX (SPCX) call put ratio 1.5 calls to 1 put as share price up 1.4%
• UBS says bull market has further to run